(Q43698946)

English

Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.

scientific article published in August 2001

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

title

Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

Oliver W Press

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

author name string

Shan D

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

language of work or name

English

0 references

publication date

1 August 2001

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

volume

7

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

issue

8

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

page(s)

2490-2495

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 November 2019

Identifiers

PubMed ID

11489831

1 reference

stated in

Europe PubMed Central

PubMed ID

11489831

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11489831%20AND%20SRC:MED&resulttype=core&format=json

(Q43698946)

Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)